Elaine E. Wang, MD

Sr. Medical Director
Seres Therapeutics
Cambridge, Massachusetts, United States

Seres Therapeutics (Employee)

Presentation(s):

• 19 - The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial

  On Demand